AstraZeneca
Japan Drug Master Files (JDMF)
AstraZeneca
Japan DMF Database
Japan Drug Master Files (JDMF) registered with Japan's Pharmaceuticals and Medical Devices Agency (PMDA).
- Total Records 12
- Latest Registration 2023-11-15
- Data Source PMDA
- Last Updated 2023-11-15
Company Overview
Company
AstraZeneca
Country
United Kingdom
Website
Social Profiles
Company Snapshot
AstraZeneca
2 Kingdom Street, Paddington, London W2 6BD
United Kingdom
www.astrazeneca.com/ Russell.Gantt@astrazeneca.com View on MapJDMF Records Timeline (12 records)
Product
Culture medium / Culture medium additives - Nircevimab (recombinant) Culture medium additive B
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
305MF40040
Domestic Manager
Initial Registration
2023-11-15
Latest Registration
2023-11-15
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 305MF40040
Product
Culture medium / Culture medium additives - Nircevimab (recombinant) Culture medium additive A
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
305MF40039
Domestic Manager
Initial Registration
2023-11-15
Latest Registration
2023-11-15
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 305MF40039
Product
Culture medium / Culture medium additive - Nircevimab (recombinant) production medium
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
305MF40038
Domestic Manager
Initial Registration
2023-11-15
Latest Registration
2023-11-15
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 305MF40038
Product
Culture medium/culture medium additives - Nircevimab (recombinant) inoculant medium
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
305MF40037
Domestic Manager
Initial Registration
2023-11-15
Latest Registration
2023-11-15
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 305MF40037
Product
Culture medium / Culture medium additives - Tralokinumab Production Media in production stage
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
304MF40033
Domestic Manager
Initial Registration
2022-09-21
Latest Registration
2022-09-21
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 304MF40033
Product
Culture medium / Culture medium additives - Tralokinumab Production Media in N-1 stage
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
304MF40032
Domestic Manager
Initial Registration
2022-09-21
Latest Registration
2022-09-21
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 304MF40032
Product
Culture medium / Culture medium additives - Tralokinumab Production Media
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
303MF40061
Domestic Manager
Initial Registration
2021-09-02
Latest Registration
2021-09-02
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 303MF40061
Product
Culture medium / Culture medium additive - Tralokinumab Inoculum Media
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
303MF40060
Domestic Manager
Initial Registration
2021-09-02
Latest Registration
2021-09-02
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 303MF40060
Product
Culture medium / Culture medium additives - Inebilizumab Production Media
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
303MF40041
Domestic Manager
Initial Registration
2021-07-06
Latest Registration
2021-07-06
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 303MF40041
Product
Culture medium / Culture medium additive - Inebilizumab Inoculum Media
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
303MF40003
Domestic Manager
Initial Registration
2021-01-26
Latest Registration
2021-01-26
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 303MF40003
Product
Culture medium / Culture medium additives - Inebelizumab Production Media
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
303MF40004
Domestic Manager
Initial Registration
2021-01-26
Latest Registration
2021-01-26
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 303MF40004
Product
Culture medium / Culture medium additives - Inebilizumab Media
Company
AstraZeneca Pharmaceuticals LP
MF Registration No.
302MF40018
Domestic Manager
Initial Registration
2020-06-04
Latest Registration
2020-06-04
Registered Address
One MedImmune Way, Gaithersburg, MD 20878, USA
Country
Identifiers
MF Registration No.: 302MF40018
Official Source
All data is sourced from publicly available Japanese pharmaceutical regulatory sources and PMDA related publications.
Visit PMDARecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
Identifiers
MF Registration No.: 305MF40040
100% Official Data
Compiled from official PMDA & Japanese regulatory sources
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.